HIV: Search for a cure now in its second decade: Scientific rivalry overshadowed French team's discovery in 1983
Steve Connor is the Science Editor of The Independent. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; twice commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigative journalism. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Thursday 04 August 1994
Scientists have broken down the genetic structure of HIV. They understand how it passes from one person to another and how it infects cells.
Despite this, however, the virus has proven a formidable opponent for the drugs and potential vaccines being developed to fight it. A cure is a distant prospect.
It was a team of French researchers, led by Luc Montagnier at the Pasteur Institute in Paris, who first identified the virus in 1983. But the discovery was overshadowed by work from a rival team of American researchers, led by Robert Gallo of the US National Cancer Institute near Washington DC.
Dr Gallo believed that the French were wrong and proposed that Aids was caused by a class of viruses known to be implicated in cancer. A year later, in April 1984, he announced his own discovery of a virus he called HTLV-3, which he wrongly claimed was similar to a leukaemia virus that he believed caused Aids.
A genetic analysis in the following year, however, revealed that the HTLV-3 virus was identical to the virus discovered by Montagnier's group. Both viruses were eventually renamed HIV - human immunodeficiency virus - and years later Gallo had to admit that HTLV-3 was a laboratory contamination. The French virus had somehow found its way into the American test-tubes.
Once scientists had identified what caused Aids, it was a relatively simple, yet vital, step to develop a blood test to identify infected people and protect blood supplies for transfusion patients and haemophiliacs. Britain introduced a test for screening blood donations in October 1985.
Identifying the virus also meant scientists could learn about its genetic structure. What genes it had and what they did? How might drugs be developed to block its life-support systems? Could vaccines help the body's immune defences to mount an effective attack on HIV's life cycle?
Unfortunately there were no simple answers to those questions.
Scientists quickly realised they were dealing with a formidable foe which possessed the ability to mutate faster than the flu virus, making it a constantly moving target for vaccines which work by stimulating the body's natural defences to attack an invading virus.
HIV also possesssed the attribute of integrating its genes into the genetic material of the people it infects. No drug or vaccine has been developed that can winkle out such rogue viruses.
A further difficulty is that HIV also infects the very cells that are supposed to prevent microbes invading the body - cells designed to engulf viruses and rip them apart with enzymes.
But instead of being destroyed at the point of entry, HIV takes up residence within the cell which acts as a Trojan Horse, carrying the virus deeper into the body's more vulnerable regions, such as the lymph glands.
And there is the long latency period between infection and the onset of Aids. It is not clear why it takes so long for the virus to trigger a collapse of the immune defences and scientists can only speculate on why some people are better survivors than others. Good nutrition and early medical intervention seem to lengthen the incubation period.
But one thing they are sure of: the long period of latency, when infected people can unwittingly pass on the virus before they develop symptoms, has turned out to be the most potent mechanism for the spread of HIV.
David Cameron stung by jellyfish: PM hurt after ignoring advice of locals while on holiday
South Korea ferry: Vice principal rescued from sinking ship found hanged
Oscar Pistorius trial: The case against Oscar Pistorius – and why the prosecution claims his story doesn't add up
Peaches Geldof funeral: Private ceremony to be held at same place as her mother Paula Yates on Easter Monday
Shropshire criminals ‘using unmanned drones and infrared cameras to find illegal cannabis farms’ – and then steal from the growers
The food poverty scandal that shames Britain: Nearly 1m people rely on handouts to eat – and benefit reforms may be to blame
US Navy christens huge $3 billion destroyer ship USS Zumwalt that appears as a fishing boat on enemy radar
Scottish independence: It is the English who should be on their knees, begging the Scots to vote ‘No’
Nigel Farage fatigue? Half of voters ‘immune’ to Ukip’s appeal
Nigel Farage: I’m taking on the status quo, and the Establishment’s fighting back
Refugee facing deportation from Sweden saved by fellow passengers refusing to let plane leave
- 1 Are you turning into your dad? The top ten signs you've embraced dad-ism revealed as survey says 38 is age men turn into their father
- 2 Overheard in Waitrose: documenting the chatter in 'Britain's poshest supermarket'
- 3 Video of British Muslims dancing to Pharrell Williams's hit Happy attacked as 'sinful'
- 4 24 people applied for the 'world's toughest job', here are their interviews
- 5 Grace Dent on TV: Game of Thrones has jumped the shark
£150.00 per week: QA Apprenticeships: This company is a company that specializ...
£153.75 per week: QA Apprenticeships: This company is an innovative outsourcin...
£150.00 per week: QA Apprenticeships: This company has been providing on site ...
£150.00 per week: QA Apprenticeships: We've been supplying best of breed peopl...